Octreotide shows up on exams exactly the way it shows up in the hospital: as the “shut it down” drug for hormone-driven diarrhea and GI bleeding. If you can remember what it mimics and what it stops, you’ll nail most Step questions.
The Mnemonic: “OCTREO-TIDE pulls the TIDE out”
Picture a beach where the tide (GI secretions + splanchnic blood flow) is rushing in. Octreotide arrives and pulls the tide out, leaving everything dry and calm.
Visual hook (mental image)
- “OCTREO” = an octopus wrapping its tentacles around:
- a faucet (GI hormone secretion)
- a blood vessel (splanchnic blood flow)
- The octopus tightens → less secretion + less portal flow
One-liner
Octreotide is a somatostatin analog that “turns off” GI hormone release and reduces splanchnic blood flow—great for carcinoid symptoms and variceal bleeding.
Mechanism (high-yield)
Octreotide = long-acting somatostatin analog
It inhibits release of:
- Serotonin and other peptides (carcinoid)
- VIP (VIPoma)
- Growth hormone (acromegaly)
- Insulin & glucagon (important for adverse effects)
- Gastrin (clinically relevant in some secretory states)
It also:
- Decreases splanchnic/portal blood flow → helps control esophageal variceal hemorrhage
Rapid-Fire Indications (what Step loves)
1) Carcinoid syndrome
Carcinoid tumor (often metastatic to liver) → episodic:
- Flushing
- Watery diarrhea
- Wheezing/bronchospasm
- +/- right-sided valvular disease
Octreotide reduces hormone-mediated symptoms (esp diarrhea/flushing).
2) Esophageal variceal bleeding
In portal HTN, octreotide:
- Vasoconstricts splanchnic circulation
- Decreases portal venous inflow
- Often used acutely along with endoscopic therapy.
3) VIPoma
VIP → “pancreatic cholera”:
- Watery diarrhea
- Hypokalemia
- Achlorhydria
Classic board stem: massive secretory diarrhea that continues with fasting.
Octreotide helps by suppressing VIP release.
4) Acromegaly (Step 1 crossover)
Somatostatin analogs (octreotide/lanreotide) suppress GH.
Quick Table: “Pulls the tide out” = what gets pulled back?
| What’s “too high”? | Clinical problem | Octreotide effect |
|---|---|---|
| GI hormones (VIP, serotonin, etc.) | Secretory diarrhea, flushing | ↓ Hormone secretion |
| Portal/splanchnic blood flow | Variceal hemorrhage | ↓ Portal inflow |
| GH | Acromegaly | ↓ GH release |
Adverse Effects (don’t miss these)
Boards love the “shut down GI and gallbladder” consequences:
- GI upset: nausea, abdominal pain, diarrhea/steatorrhea (yes—ironically)
- Gallstones: ↓ CCK → ↓ gallbladder contraction → cholesterol gallstones
- Glucose disturbances: inhibits insulin and glucagon → can cause hypoglycemia or hyperglycemia
- Bradycardia (less common but testable)
Mini-mnemonic for side effects:
“OCTREO = Oily poop, Cholelithiasis, Trouble with glucose, Reduce hormones, Esophageal varices, Off portal flow”
Exam-Style Clues (pattern recognition)
- Watery diarrhea that persists with fasting + hypokalemia → think VIPoma → octreotide
- Flushing + wheezing + diarrhea → carcinoid syndrome → octreotide
- Cirrhosis + hematemesis from varices → octreotide to reduce portal flow
Takeaway
If you remember “OCTREO-TIDE pulls the TIDE out,” you’ll recall the two biggest testable uses:
- Stops hormone-driven secretory symptoms (carcinoid, VIPoma)
- Stops portal “flooding” (variceal bleeding)